Department of Medicine, Queen Elizabeth Hospital, Hong Kong, SAR, People's Republic of China.
SEARCH, Thai Red Cross AIDS Research Centre, 104 Ratchadamri Rd, Khwaeng Pathum Wan, Khet Pathum Wan, Krung Thep Maha Nakhon, Bangkok, 10330, Thailand.
BMC Infect Dis. 2019 Feb 13;19(1):156. doi: 10.1186/s12879-019-3784-y.
HIV-associated neurocognitive disorder (HAND) remains prevalent in the era of combination antiretroviral therapy (cART). The prevalence of HAND in Hong Kong is not known.
Between 2013 and 2015, 98 treatment-naïve HIV-1-infected individuals were referred to and screened by the AIDS Clinical Service, Queen Elizabeth Hospital with (1) the International HIV Dementia Scale (IHDS), a screening tool that targets moderate to severe HAND, (2) the Montreal Cognitive Assessment (MoCA), a frequently used cognitive screening test and (3) the Patient Health Questionnare-9 (PHQ-9), a 9-item questionnaire that evaluates depression symptoms. Within the study period, 57 of them completed the second set of IHDS and MoCA at 6 months after baseline assessment.
Most participants were male (94%), with a median age of 31 years. At baseline, 38 (39%) and 25 (26%) of them scored below the IHDS (≤10) and MoCA (25/26) cut-offs respectively. Poor IHDS performers also scored lower on MoCA (p = 0.039) but the correlation between IHDS and MoCA performance was weak (r = 0.29, p = 0.004). Up to a third of poor IHDS performers (13/38) showed moderate depression (PHQ-9 > 9). In the multivariable analysis, a lower education level (p = 0.088), a history of prior psychiatric illness (p = 0.091) and the presence of moderate depression (p = 0.079) tended to be significantly associated with poor IHDS performance. At follow-up, 54 out of 57 were on cART, of which 46 (85%) had achieved viral suppression. Their blood CD4+ T-lymphocytes and IHDS scores were higher at follow-up compared to baseline values (both p < 0.001) but their MoCA performance was similar at both assessments. Of note, 17 participants in this subgroup scored below the IHDS cut-off at both assessments.
Poor IHDS performance, and likely cognitive impairment, was frequently observed in treatment-naïve HIV-infected individuals in our locality. A considerable proportion continued to score below the IHDS cut-off at 6 months after cART. Depression was frequently observed in this vulnerable population and was associated with poor IHDS performance.
在联合抗逆转录病毒疗法(cART)时代,HIV 相关神经认知障碍(HAND)仍然普遍存在。香港 HAND 的患病率尚不清楚。
2013 年至 2015 年期间,98 名未经治疗的 HIV-1 感染患者通过艾滋病临床服务中心(伊丽莎白女王医院)进行了(1)国际 HIV 痴呆量表(IHDS)、(2)蒙特利尔认知评估(MoCA)和(3)患者健康问卷-9(PHQ-9)筛查,以确定是否存在 HAND。IHDS 是一种针对中度至重度 HAND 的筛查工具,MoCA 是一种常用的认知筛查测试,PHQ-9 是一种评估抑郁症状的 9 项问卷。在此研究期间,其中 57 名患者在基线评估后 6 个月完成了第二套 IHDS 和 MoCA 评估。
大多数参与者为男性(94%),中位年龄为 31 岁。基线时,38 名(39%)和 25 名(26%)患者的 IHDS(≤10)和 MoCA(25/26)评分低于截断值。表现不佳的 IHDS 患者在 MoCA 上的得分也较低(p=0.039),但 IHDS 和 MoCA 表现之间的相关性较弱(r=0.29,p=0.004)。多达三分之一的 IHDS 评分较低的患者(13/38)表现出中度抑郁(PHQ-9>9)。多变量分析显示,较低的教育程度(p=0.088)、既往精神病史(p=0.091)和中度抑郁(p=0.079)与 IHDS 评分不佳显著相关。在随访时,57 名患者中有 54 名正在接受 cART,其中 46 名(85%)病毒得到抑制。他们的血液 CD4+T 淋巴细胞和 IHDS 评分在随访时均高于基线值(均 p<0.001),但在两次评估中 MoCA 评分相似。值得注意的是,该亚组中有 17 名患者在两次评估中均低于 IHDS 截断值。
在我们当地的未经治疗的 HIV 感染者中,经常观察到 IHDS 评分不佳,可能存在认知障碍。在 cART 后 6 个月,相当一部分患者的 IHDS 评分仍低于截断值。在这一弱势群体中经常观察到抑郁,并且与 IHDS 评分不佳有关。